Centre for Geographic Medicine Research (Coast), Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya.
College of Health Sciences, Makerere University, Kampala, Uganda.
Front Immunol. 2024 Apr 8;15:1360220. doi: 10.3389/fimmu.2024.1360220. eCollection 2024.
Malaria remains a major global health priority, and monoclonal antibodies (mAbs) are emerging as potential new tools to support efforts to control the disease. Recent data suggest that Fc-dependent mechanisms of immunity are important mediators of protection against the blood stages of the infection, but few studies have investigated this in the context of mAbs. We aimed to isolate mAbs agnostic to cognate antigens that target whole merozoites and simultaneously induce potent neutrophil activity measured by the level of reactive oxygen species (ROS) production using an antibody-dependent respiratory burst (ADRB) assay.
We used samples from semi-immune adults living in coastal Kenya to isolate mAbs that induce merozoite-specific ADRB activity. We then tested whether modifying the expressed IgG1 isotype to an IgG-IgA Fc region chimera would enhance the level of ADRB activity.
We isolated a panel of nine mAbs with specificity to whole merozoites. mAb J31 induced ADRB activity in a dose-dependent fashion. Compared to IgG1, our modified antibody IgG-IgA bi-isotype induced higher ADRB activity across all concentrations tested. Further, we observed a negative hook effect at high IgG1 mAb concentrations (i.e., >200 µg/mL), but this was reversed by Fc modification. We identified MSP3.5 as the potential cognate target of mAb J31.
We demonstrate an approach to engineer mAbs with enhanced ADRB potency against blood-stage parasites.
疟疾仍然是全球主要的卫生重点之一,单克隆抗体(mAbs)作为控制疾病的潜在新工具正在出现。最近的数据表明,Fc 依赖性免疫机制是抵抗感染血阶段的重要保护介质,但很少有研究在 mAbs 的背景下对此进行研究。我们旨在分离针对整个疟原虫且同时诱导中性粒细胞活性的 mAbs,中性粒细胞活性通过活性氧(ROS)产生水平来衡量,使用抗体依赖性呼吸爆发(ADRB)测定法。
我们使用来自生活在肯尼亚沿海地区的半免疫成年人的样本来分离诱导疟原虫特异性 ADRB 活性的 mAbs。然后,我们测试了修饰表达的 IgG1 同种型为 IgG-IgA Fc 区嵌合体是否会增强 ADRB 活性的水平。
我们分离出了一组针对整个疟原虫的九种 mAbs。mAb J31 以剂量依赖性方式诱导 ADRB 活性。与 IgG1 相比,我们修饰的抗体 IgG-IgA 双同种型在所有测试浓度下都诱导了更高的 ADRB 活性。此外,我们在高 IgG1 mAb 浓度(即>200μg/ml)下观察到负钩效应,但通过 Fc 修饰得到了逆转。我们确定 MSP3.5 是 mAb J31 的潜在同源靶标。
我们展示了一种针对血阶段寄生虫增强 ADRB 效力的 mAbs 工程方法。